__timestamp | Biogen Inc. | Corcept Therapeutics Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 8532288000 | 25669000 |
Thursday, January 1, 2015 | 9523400000 | 48925000 |
Friday, January 1, 2016 | 9970100000 | 79263000 |
Sunday, January 1, 2017 | 10643900000 | 155647000 |
Monday, January 1, 2018 | 11636600000 | 246032000 |
Tuesday, January 1, 2019 | 12422500000 | 300982000 |
Wednesday, January 1, 2020 | 11639400000 | 348292000 |
Friday, January 1, 2021 | 8872000000 | 360697000 |
Saturday, January 1, 2022 | 7895100000 | 396473000 |
Sunday, January 1, 2023 | 7302200000 | 475894000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Biogen Inc. and Corcept Therapeutics Incorporated have showcased contrasting trajectories in their gross profit margins. From 2014 to 2023, Biogen's gross profit peaked in 2019, reaching approximately 12.4 billion, before experiencing a decline of about 41% by 2023. In contrast, Corcept Therapeutics has demonstrated a remarkable growth story, with its gross profit increasing by an impressive 1,750% over the same period.
This analysis highlights the dynamic nature of the biotech industry, where innovation and strategic decisions can lead to significant financial shifts. As Biogen navigates its challenges, Corcept's upward trend underscores the potential for smaller companies to make substantial gains in a competitive market. Investors and industry watchers should keep a close eye on these developments as they unfold.
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Healthcare Companies
Number of Employees for Top 10 Pharma Companies
Average Market Capitalization of Abbvie Annually
5 Year Trend in Market Capitalization for AbbVie
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters